New Cancer Test Helps Men Reduce Unnecessary Prostate Biopsies

Prostate cancer is the most prevalent cancer in American males, according to the American Cancer Society (ACS), other than skin cancer. The ACS estimates that roughly 174,650 fresh prostate cancer instances and 31,620 fatalities will occur in 2019. During his lifetime, approximately 1 person in 9 will be diagnosed with prostate cancer. Prostate cancer primarily grows in elderly males and African-American males. The Next Generation Test for Prostate Cancer While Prostate Specific Antigen (PSA) is presently the most commonly used prostate cancer screening test, it is commonly acknowledged that PSA findings may suggest prostate cancer when none is present. The Prostate Health Index (phi) is an FDA-approved blood test that can assist distinguish prostate cancer from benign prostate circumstances in males. As part of a advanced algorithm, the Prostate Health Index uses three distinct PSA markers (PSA, freePSA, and p2PSA) to determine the likelihood of cancer in patients with high PSA concentrations more reliably and can assist people and their physicians decide whether a prostate biopsy is indicated. Like many males who are told they have elevated PSA, Jim Robinson was worried about prostate cancer. "I certainly didn't want to delay treatment if I had prostate cancer, but if I didn't need one, I was also worried about a prostate biopsy." Jim's tale is not uncommon, after all, surveys have shown that about 70 percent of males with high PSA who have a biopsy do not have cancer. Besides prostate cancer, a number of benign (not cancerous) circumstances can cause a man's PSA to increase. Prostatitis (inflammation of the prostate) and benign prostatic hyperplasia (BPH) (enlargement of the prostate) are the most common benign prostate conditions that trigger increase in PSA levels. The Prostate Health Index is included as a blood test to enhance the specificity of prostate cancer detection in the National Comprehensive Cancer Network Guideline for Prostate Cancer Early Detection. The Prostate Health Index is stated with an elevated PSA between 4ng / ml and 10ng / ml for males aged 50 years and older. Patients Can Order The Test Online Men who want to have a higher say in their therapy and want the Prostate Health Index test completed at their request can now start a physician order online through a network of telehealth physicians that can tackle the instant need for a patient to be evaluated and assist direct their management. In order to integrate outcomes into their therapy plans, patients are recommended to share their test report with their periodic healthcare experts.

Posted using Partiko Android